Literature DB >> 23981336

Pure insulin highly respirable powders for inhalation.

Anna Giulia Balducci1, Stefano Cagnani, Fabio Sonvico, Alessandra Rossi, Pedro Barata, Gaia Colombo, Paolo Colombo, Francesca Buttini.   

Abstract

The aim of the present research was to investigate the possibility to obtain by spray drying an insulin pulmonary powder respirable and stable at room temperature without the use of excipients. Several insulin spray-dried powders were prepared with or without the addition of excipients (mannitol, bovine serum albumin, aspartic acid) from water dispersions or from acidic aqueous solutions. Each formulation was characterized using laser diffraction, scanning electron microscopy and in vitro aerosol performance with a Turbospin DPI device. Stability was assessed by the quantification of impurities with a molecular mass greater than that of insulin (HMWP) and related proteins (A21+ORP). Insulin powders prepared without excipients from an acid solution showed a shrivelled, raisin-like shape of non-aggregated microparticles and a high respirability (FPF>65%). The optimal result with respect to respirability and stability was reached when the pH of the insulin acetic acid solution to spray dry was adjusted at pH 3.6 with ammonium hydroxide. The median volume diameter of the obtained powder was 4.04 μm, insulin content 95%, emitted dose of 89.5%, MMAD 1.79 μm and fine particle fraction of 83.6%. This powder was stable at room temperature over a period of eighteen months with respect to the content of A21+ORP. As far as the HMWP content was concerned, the powder complied with the specification limits for a period of five months. The insulin acetic powder opens up the possibility of a more effective pulmonary therapy less dependent on refrigerated storage.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Excipient-free; Inhalation powder; Insulin; Microparticles; Pulmonary drug delivery; Spray-drying

Mesh:

Substances:

Year:  2013        PMID: 23981336     DOI: 10.1016/j.ejps.2013.08.009

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  5 in total

Review 1.  Inhaled insulin: A "puff" than a "shot" before meals.

Authors:  Dick B S Brashier; Anjan Khadka; Tejus Anantharamu; Ashok Kumar Sharma; A K Gupta; Sushil Sharma; N Dahiya
Journal:  J Pharmacol Pharmacother       Date:  2015 Jul-Sep

2.  Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders.

Authors:  Rita Patrizia Aquino; Mariateresa Stigliani; Pasquale Del Gaudio; Teresa Mencherini; Francesca Sansone; Paola Russo
Journal:  ScientificWorldJournal       Date:  2014-12-16

Review 3.  Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2016-10-27

Review 4.  Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides.

Authors:  Basanth Babu Eedara; Wafaa Alabsi; David Encinas-Basurto; Robin Polt; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2021-06-18       Impact factor: 4.026

5.  In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.

Authors:  Alessandro Giuliani; Anna Giulia Balducci; Elisa Zironi; Gaia Colombo; Fabrizio Bortolotti; Luca Lorenzini; Viola Galligioni; Giampiero Pagliuca; Alessandra Scagliarini; Laura Calzà; Fabio Sonvico
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.